C4 Therapeutics, Inc.

CCCCReported to SECin USCIK 0001662579Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at C4 Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Adams KendraChief Financial OfficerAdministrative$9,4072,775 sharesSep 21, 2026Adams KendraChief Financial Officer$9,407Admin · Sep 21Administrative2,775Sep 21, 2026
Adams KendraChief Financial OfficerOption exercisenothing paid6,250 sharesSep 21, 2026Adams KendraChief Financial Officernothing paidExercise · Sep 21Option exercise6,250Sep 21, 2026
REYNO LEONARDChief Medical OfficerAdministrative$30,0327,397 sharesJul 13, 2026REYNO LEONARDChief Medical Officer$30,032Admin · Jul 13Administrative7,397Jul 13, 2026
REYNO LEONARDChief Medical OfficerOption exercisenothing paid15,325 sharesJul 13, 2026REYNO LEONARDChief Medical Officernothing paidExercise · Jul 13Option exercise15,325Jul 13, 2026
GROGAN DONNA ROY—Award$14,5003,341 sharesJul 2, 2026GROGAN DONNA ROY$14,500Award · Jul 2Award3,341Jul 2, 2026